CABA · Cabaletta Bio, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“We have identified conditions that raise substantial doubt about our ability to continue as a going concern. If we are unable to secure additional funding beyond our current cash position that enables our operations into mid-2027, we may be forced to delay, reduce or discontinue our product development programs efforts or other operations.”